FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386977009: Daclizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461155012 Daclizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481091011 Daclizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461155012 Daclizumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1461155012 Daclizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481091011 Daclizumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481091011 Daclizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
376351000195110 daclizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
803581000172119 daclizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
803581000172119 daclizumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
376351000195110 daclizumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclizumab (substance) Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab (substance) Is a anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab (substance) Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab (substance) Has disposition Immunomodulator (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab (substance) Is a Immunosuppressant (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing daclizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Daclizumab 25mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab 25mg/5mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab 25mg/5mL conventional release solution for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Daclizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Daclizumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Daclizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Daclizumab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start